Neuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma CasesCancer, Hypoxia, and MetabolismCancer therapeutics and mechanismsGlioma Diagnosis and Treatment
Publications
149
Citations
5,997
Est. group size
—
Recurring co-author estimate
Active years
71
Publishing since 1955
Publication cadence
Publications per year over the last 10 years — averaging 11.2/year recently
Recent publications
- Phase I Study of <sup>131</sup> I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
Journal of Clinical Oncology · 2025
- Hemodynamics are associated with subsequent lumen remodeling and clinical maturation of hemodialysis arteriovenous fistula
Scientific Reports · 2025
- A phase 1 dose‐escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma
Cancer · 2025
- Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma
JAMA Network Open · 2025
- Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study
Transplantation and Cellular Therapy · 2025
- Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas
Journal of Clinical Oncology · 2025
- Abstract 5340: Simultaneous targeting of CDK4/6 and BETs is independent of RB status in osteosarcoma
Cancer Research · 2025
- Single-cell and Spatial Omics Reveals Region-Specific Plasticity and Therapeutic Vulnerabilities in Metastatic High-Risk Neuroblastoma
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study
Transplantation and Cellular Therapy · 2025
- Abstract 7045: Anti-tumor effects following BET inhibition in preclinical models of pediatric and AYA osteosarcoma
Cancer Research · 2025
- The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma
Human Genetics · 2025
- Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors
JACC CardioOncology · 2024
- Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Nature Medicine · 2024
- Tailored ECMO for Respiratory Failure: Moving From Off-the-Rack to Bespoke
ASAIO Journal · 2024
- NFS-18. LOWER BODY SURFACE AREA IS ASSOCIATED WITH INCREASED LIKELIHOOD OF PLEXIFORM NEUROFIBROMA RESPONSE TO MEK INHIBITION
Neuro-Oncology · 2024
Publishes in
- Journal of Clinical Oncology×16
- Neuro-Oncology×10
- Pediatric Blood & Cancer×6
- Transplantation and Cellular Therapy×3
- Cancer Research×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile